MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3928/23258160-20200228-03

Медицинская библиотека · Ophthalmic surgery, lasers & imaging retina · 2020

Intravitreal Ziv-Aflibercept in Patients With Diabetic Macular Edema Refractory to Intravitreal Bevacizumab.

Ebrahimiadib Nazanin, Lashay Alireza, Riazi-Esfahani Hamid, Jamali Sepideh, Khodabandeh Alireza, Zarei Mohammad, Roohipoor Ramak, Khojasteh Hassan, Bazvand Fatemeh, Ojani Mina, Shahabinejad Mojtaba, Yaseri Mehdi, Modjtahedi Bobeck S, Davoudi Samaneh, Riazi-Esfahani Mohammad

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND AND

OBJECTIVE

To evaluate the efficacy of intravitreal ziv-aflibercept (IVZ) in patients with diabetic macular edema (DME) resistant to intravitreal bevacizumab (IVB).

PATIENTS AND

METHODS

This prospective study was conducted in patients with persistent DME. Patients were switched to IVZ no longer than 6 weeks after the last three consecutive monthly IVB treatments and monitored over a course of 12 weeks. Changes in best-corrected visual acuity (BCVA), central macular thickness (CMT), and macular volume on optical coherence tomography were compared.

RESULTS

A total of 59 eyes (38 patients) were included. Mean BCVA improved from 0.84 to 0.71 logMAR (P = .001) after first IVZ treatment and remained significant. In a subgroup analysis, this significance was observed only in the group with baseline visual acuity of less than 20/50. Mean CMT decreased from 479 μm to 364 μm (P = .004) after the first IVZ injections and remained significant.

CONCLUSION

IVZ may be best reserved for patients with persistent DME after initial failure with bevacizumab, with less likelihood for anatomic or functional improvement in those with mild persistent DME. [Ophthalmic Surg Lasers Imaging Retina. 2020;51:145-151.].

Для цитирования: Ebrahimiadib Nazanin, Lashay Alireza, Riazi-Esfahani Hamid, Jamali Sepideh, Khodabandeh Alireza, Zarei Mohammad, Roohipoor Ramak, Khojasteh Hassan, Bazvand Fatemeh, Ojani Mina, Shahabinejad Mojtaba, Yaseri Mehdi, Modjtahedi Bobeck S, Davoudi Samaneh, Riazi-Esfahani Mohammad. Intravitreal Ziv-Aflibercept in Patients With Diabetic Macular Edema Refractory to Intravitreal Bevacizumab.. Ophthalmic surgery, lasers & imaging retina. 2020. DOI: 10.3928/23258160-20200228-03.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.